The EuroPCR Course Directors have chosen three major late-breaking trials to be unveiled at EuroPCR 2025. These were selected ...

With the new analysis, researchers rule out embolic protection for stroke prevention in TAVI, but not everybody has given up.

“We are excited to share significant findings from the post hoc analysis of the phase 2a clinical trial of ENV-101, highlighting our pulmonary vessel volume quantification model, Vascul8 ...

The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time ...

Viridian Therapeutics’ veligrotug has shown one-year durability in a Phase III trial in patients with active thyroid eye ...

A UK study found that a 12-week intervention to reduce sedentary behavior was well accepted by ethnically diverse older ...

Britain’s ailing courts system now has trials scheduled to open no sooner than 2029 – almost four years away – as the ...

A new analysis found that red meat studies with industry links were more likely to report favorable results than those ...

Co-CEO Jake Junkil Been joins Industry Collaboration Session to present Neurophet's brain imaging analysis technologies, ...

New review confirms psychiatric safety of commonly used glucagon-like peptide 1 receptor agonists among patients without ...

The agency said it would approve new versions of the vaccine only for adults 65 years of age and older as well as for people with one or more risk factors for severe COVID-19 outcomes. These risk ...

Popular herbs and supplements for high blood pressure include teas, omega-3s, and garlic. Here’s how to lower blood pressure ...